Goldman Sachs Issues Buy Rating for Hologic, Noting Contributions from Gen-Probe Purchase
August 07, 2012
Goldman Sachs Issues Buy Rating for Hologic, Noting Contributions from Gen-Probe Purchase
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Goldman Sachs Initiates Coverage of Four MDx Firms
February 23, 2011 / GenomeWeb Daily News - Gen-Probe Acquisition Drives up Hologic's Q2 Revenues 30 Percent
May 6, 2013 / GenomeWeb Daily News - Cepheid Highlights Strong Uptake of Xpert CT/NG as Q1 Revenues Rise 19 Percent
April 25, 2013 / PCR Insider - Dx Focus: BD Max Cdiff; Hologic Aptima HPV; Inostics BEAMing Tech; Veredus Labs VereFlu Test
April 11, 2013 / PCR Insider - On Heels of FDA Approval, Cepheid's Xpert CT/NG Test Performs Well in Multi-Center Clinical Study
March 14, 2013 / PCR Insider